A Study Designed to Evaluate the Pharmacokinetic Profile of Abiraterone

NCT04295161 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics

Interventions

DRUG: Abiraterone Acetate

Sponsor

Zentiva, k.s.